Mary Pat Lancelotta
Public Communications Contact bei ADAPTIVE BIOTECHNOLOGIES CORPORATION
Aktive Positionen von Mary Pat Lancelotta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Public Communications Contact | - | - |
| Vertrieb & Marketing | - | - | |
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 19.08.2021 | - |
| Independent Dir/Board Member | 19.08.2021 | - | |
| Target Cancer Foundation | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Mary Pat Lancelotta
Ehemalige bekannte Positionen von Mary Pat Lancelotta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Lumicell, Inc.
 Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Mary Pat Lancelotta
| Boston College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Electronic Technology |
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |
| Target Cancer Foundation |
- Börse
- Insiders
- Mary Pat Lancelotta
- Erfahrung
